Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I am assuming that the

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Jul 28, 2023 8:11am

329 Views

Post# 35561139

RE:I am assuming that the

Yes summer will be over, more data, more time lapsed for BTD/AA to be approved. Also, I read an article today about preparedness for the NEXT pandemic with a 'made in Canada' vaccine so while everything seems to take a long time we are definitely in the right place with TLT, maybe we get some news on that front in the fall.

Oden6570 wrote: Next news we get from TLT is quarterly update end of August. Perhaps we get suprising news prior to then but summer tends to be a very quiet time for most companies.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments